BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25283341)

  • 21. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.
    Arime Y; Kasahara Y; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2012 Oct; 37(11):2522-30. PubMed ID: 22781838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
    Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
    Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
    Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers.
    Deslauriers J; Larouche A; Sarret P; Grignon S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():156-64. PubMed ID: 23697796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.
    Kusljic S; Copolov DL; van den Buuse M
    Neuropsychopharmacology; 2003 Dec; 28(12):2138-47. PubMed ID: 12888784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.
    Calipari ES; Ferris MJ; Salahpour A; Caron MG; Jones SR
    Nat Commun; 2013; 4():2720. PubMed ID: 24193139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice.
    Meyer U; Nyffeler M; Yee BK; Knuesel I; Feldon J
    Brain Behav Immun; 2008 May; 22(4):469-86. PubMed ID: 18023140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia.
    Vaillancourt C; Boksa P
    Neuropsychopharmacology; 2000 Dec; 23(6):654-66. PubMed ID: 11063921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo.
    Vecchio LM; Bermejo MK; Beerepoot P; Ramsey AJ; Salahpour A
    Mol Cell Neurosci; 2014 Jul; 61():123-32. PubMed ID: 24886986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
    Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
    Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypomethylation of neuregulin in rats selectively bred for reduced sensorimotor gating.
    Rhein M; Muschler MR; Krauss JK; Bleich S; Frieling H; Schwabe K
    Schizophr Res; 2013 Oct; 150(1):262-5. PubMed ID: 23899995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.
    Rodríguez VM; Limón-Pacheco JH; Mendoza-Trejo MS; González-Gallardo A; Hernández-Plata I; Giordano M
    Neurotoxicology; 2013 Jan; 34():82-94. PubMed ID: 23123945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
    Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
    J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice.
    Kim DS; Palmiter RD
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1346-51. PubMed ID: 12538862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dopamine control of neuroendocrine functions. New findings based on the study of transgenic animals].
    Jaber M
    Ann Endocrinol (Paris); 1997; 58(6):427-35. PubMed ID: 9686001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
    Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
    Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the suppressor of cytokine signaling 2 (SOCS2) during meningoencephalitis caused by Bovine herpesvirus 5 (BoHV-5).
    Aparecida Silva Barbosa A; Freitas Versiani A; Fonseca da Cunha Sousa L; Silva de Miranda A; Gasparini MR; Brant F; Silva DG; Luisa Quintino-de-Carvalho I; Marianetti Soriani F; Guimarães da Fonseca F; César Vasconcelos A; da Silva Barcelos L; Martins Teixeira M; Lúcio Teixeira A; Machado FS; Barbosa-Stancioli EF; Rachid MA
    Comp Immunol Microbiol Infect Dis; 2016 Aug; 47():26-31. PubMed ID: 27477504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic system dysregulation in the mrsk2_KO mouse, an animal model of the Coffin-Lowry syndrome.
    Marques Pereira P; Gruss M; Braun K; Foos N; Pannetier S; Hanauer A
    J Neurochem; 2008 Dec; 107(5):1325-34. PubMed ID: 18823370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?
    Logue SF; Grauer SM; Paulsen J; Graf R; Taylor N; Sung MA; Zhang L; Hughes Z; Pulito VL; Liu F; Rosenzweig-Lipson S; Brandon NJ; Marquis KL; Bates B; Pausch M
    Mol Cell Neurosci; 2009 Dec; 42(4):438-47. PubMed ID: 19796684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.